Yasukazu Kawai

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou, Yuji Kishimoto, Hitoshi Kiyoi et al. · Blood · 2007 · 156 citations · Full text

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Naomi Kiyota, Martin Schlumberger, Kei Muro et al. · Cancer Science · 2015 · 128 citations · Full text

Lenvatinib Safety Profile, Similar Clinical Outcomes, Pharmacotherapy +16

Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol

Kazuo Tamura, Yasukazu Kawai, Toru Kiguchi et al. · International Journal of Clinical Oncology · 2016 · 52 citations

Urology, Medicine, Multi-center Trial +9

Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.

Adel Badran, Akira Yoshida, Yuji Wano et al. · PubMed · 2003 · 31 citations

Hematological Malignancy, Chromatin, Radiation Oncology +13

Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia: Results of a Japanese Phase II Clinical Study

Yasuo Morishima, Michinori Ogura, Miki Nishimura et al. · International Journal of Hematology · 2004 · 27 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Medicine +9